Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Treatment of HMGCR Antibody-Associated Myopathy

Initial Management

  • The American College of Cardiology recommends immediately ceasing statin therapy if the patient is currently taking one, and patients should never be re-exposed to statins after diagnosis 1
  • The American College of Cardiology and Mayo Clinic suggest that statin withdrawal alone will not control the disease, and combination therapy is required to achieve remission, with high-dose corticosteroids initiated immediately upon diagnosis 1, 2

First-Line Immunosuppression

  • Mayo Clinic recommends beginning with intravenous methylprednisolone pulse therapy (typically 1000 mg daily for 3-5 days) for severe presentations, and early addition of steroid-sparing agents prevents complications of prolonged high-dose corticosteroid use 2

Critical Pitfalls to Avoid

  • Mayo Clinic advises against relying on monotherapy with corticosteroids alone, as nearly all patients require combination therapy to achieve disease control 2